Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- González-Haba E
- Gorgas-Torner MQ
- Alonso-Herreros JM
- Cercós Lletí AC
- Calleja-Hernandez MÁ
- Delgado-Sánchez O
Grupos
Abstract
To establish a series of recommendations based on available evidence for monitoring surface contamination in the areas devoted to compounding hazardous drugs in pharmacy departments.
Datos de la publicación
- ISSN/ISSNe:
- 1130-6343, 2171-8695
- Tipo:
- Article
- Páginas:
- 96-107
- DOI:
- 10.7399/fh.11655
- PubMed:
- 33709894
- Factor de Impacto:
- 0,264 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
FARMACIA HOSPITALARIA ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 8
Documentos
- No hay documentos
Filiaciones
Keywords
- Hazardous drugs; Surface contamination; Occupational exposure; Drug compounding; Antineoplastic agents; Environmental monitoring
Cita
VALERO S,González E,Gorgas MQ,Alonso JM,Cercós AC,POVEDA JL,Calleja MÁ,Delgado O. Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH). Farm. Hosp. 2021. 45. (2):p. 96-107.
Portal de investigación